John Milligan
Net worth: 1 M $ as of 2026-05-30
Net worth: 1 M $ as of 2026-05-30
Dr. John F. Milligan is an Executive Chairman at 4D Molecular Therapeutics, Inc. and a Chairman at Pacific Biosciences of California, Inc. He is on the Board of Directors at Biotechnology Innovation Organization and Ohio Wesleyan University. Dr. Milligan was previously employed as a President by Pharmasset, Inc., a Director-Project Management by Hoffmann-La Roche, Inc., and a President, Chief Executive Officer & Director by Gilead Sciences, Inc. He received his undergraduate degree from Ohio Wesleyan University and a doctorate degree from the University of Illinois.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-19 | 100,000 ( 0.19% ) | 991 000 $ | 2026-05-30 | |
| 2026-06-02 | 132,821 ( 0.04% ) | 197 903 $ | 2026-05-30 | |
-.--% | 2026-04-16 | 0 ( -.--% ) | - $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Chairman | 2020-09-13 |
| 4D MOLECULAR THERAPEUTICS, INC. | Chairman | 2020-07-31 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Board Member | 2011-07-21 |
TurnCare, Inc.
TurnCare, Inc. Packaged SoftwareTechnology Services Develops unique technology that enhances skin and soft tissue circulation | Director/Board Member | 2023-11-30 |
| Companies | Position | End |
|---|---|---|
| GILEAD SCIENCES, INC. | Chief Executive Officer | 2018-12-30 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | President | - |
Ohio Wesleyan University
Ohio Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Chairman | - |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures sequencing system products to help scientists to resolve genetically complex problems | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Ohio Wesleyan University
Ohio Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
TurnCare, Inc.
TurnCare, Inc. Packaged SoftwareTechnology Services Develops unique technology that enhances skin and soft tissue circulation | Technology Services |
Select your edition
All financial news and data tailored to specific country editions